Nasal medicine trial for fast heart rhythm in children
Part of Heart & circulation clinical trials.
This Phase 2 trial tests whether an at-home nasal spray medicine called etripamil can help children who have episodes of a specific type of fast, irregular rhythm caused by an electrical “AV node” circuit. It mainly targets certain kids with past or confirmed episodes on heart testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 6 to under 18 years, and both boys and girls can join
- BMI is within the healthy range for age and sex (between the 5th and 85th percentiles)
- History of the specific rhythm problem: PSVT that involves the AV node (AVNRT or AVRT), confirmed by ECG or a monitor (and if they had an ablation, the rhythm must still show up after)
- You (and the child, if able) can sign consent/assent and follow study visits and procedures
- For girls or anyone who can get pregnant: negative pregnancy test and reliable birth control (or no sexual activity) are required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two simple, non-medication methods to stop sudden fast heartbeat episodes: a nasal swab technique versus a breathing exercise. Both are safe first-line treatments, and this trial helps doctors understand which works better.
This trial tests a medication called etripamil to see if it can quickly slow down a rapid heart rate during episodes of atrial fibrillation. It may help people who have frequent, long-lasting episodes with a fast heartbeat.
This study tests a treatment for supraventricular tachycardia (SVT), a condition where the heart beats too fast. It aims to see if the treatment is safe and works well in children.
This study tests an experimental drug called CRD-4730 for people with CPVT, a rare inherited heart rhythm disorder that can cause dangerous fast heartbeats during exercise or stress. The trial will see if the drug can help control these abnormal heart rhythms better than current treatments.
This study is testing a new way to detect a specific type of fast heart rhythm (called supraventricular tachycardia or SVT) in children. It may help improve how doctors find and monitor this condition in the future.
This trial studies whether a device-based fast pacing therapy (called ATP) can better treat certain rapid heart rhythm problems in people born with a heart condition. It may help prevent or reduce episodes of atrial (upper-chamber) arrhythmias that occur despite having a pacing/defibrillator device.
Hear when a new Paroxysmal Supraventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.